Physician profile
John J Moss
NPI 1588650634
$1,703.42
in general payments reported to CMS, 2019-2025
15 companies · $762 in 2025
The $762 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.15 · 2022: $324 · 2023: $143 · 2024: $447 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $335.59 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $285.43 | 2023-2025 | Belbuca |
| Abbvie INC. | $184.46 | 2023-2025 | |
| Globus Medical, INC. | $143.64 | 2025 | Senza |
| Boston Scientific Corporation | $134.41 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $114.46 | 2025 | |
| Averitas Pharma INC. | $105.40 | 2024-2025 | Qutenza |
| Medtronic, INC. | $83.89 | 2023-2025 | Invos, Synchromedii, Accurian |
| Nevro Corp. | $67.71 | 2024 | Senza |
| Avanos Medical | $66.70 | 2024-2025 | Coolief Cooled Radiofrequency, Standard Rf Disposables |
| Abbott Laboratories | $51.89 | 2025 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.85 | 2025 | Relistor |
| Spr Therapeutics, INC | $40.85 | 2023-2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $24.77 | 2024 | Exparel |
| Valinor Pharma, LLC | $16.37 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.